In a recent ruling, the Delhi High Court overturned the rejection of an anti-cancer patent filed by Taiho Pharmaceutical. The Court highlighted that objections under Section 3(d) must explicitly state the “known substance” being referenced and directed a fresh hearing for proper assessment.
Read more about Anti-Cancer Patent Refusal Set Aside for Not Identifying ‘Known Substance’Tag: known substance
Pfizer files for Patent on Known Substance
This post examines Pfizer’s patent application on a known substance and the Indian Patent Office’s refusal in light of Section 3d and the Novartis decision. It discusses whether unpublished patent applications can render a substance as “known” and critiques the merging of novelty and subject matter analysis.
Read more about Pfizer files for Patent on Known Substance